» Articles » PMID: 19761719

IgA Nephropathy in the Triethnic Population of New Mexico

Overview
Journal Clin Nephrol
Specialty Nephrology
Date 2009 Sep 19
PMID 19761719
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: IgA nephropathy (IgAN) is the most frequent glomerulonephritis around the globe, but its incidence in the United States is unknown. The disease has a preponderance for certain racial/ethnic groups. Our goals were to retrospectively analyze a series of IgAN biopsies from the state of New Mexico and to calculate an estimated incidence. Then we compared the racial/ethnic composition of our patient cohort to the composition of the New Mexico population and examined the three main racial/ethnic groups for differences in clinical and pathologic parameters.

Materials And Methods: Renal biopsies and clinical data from IgAN cases newly diagnosed in New Mexico between 2000 and 2005 were reviewed. We compared the racial/ethnic composition of our patient cohort to the demographic composition of the New Mexico population. Demographic, clinical, and histopathologic variables were analyzed with respect to the patients' race/ethnicity.

Results: The incidence of IgAN in New Mexico was 10.2 cases per million persons per year (9.3 when Henoch-Schönlein purpura cases were excluded). American Indians were twice as frequent in our patient cohort when compared to their demographic representation, with the reverse finding for Non-Hispanic Whites. Hispanics more frequently had nephrotic range proteinuria than Non-Hispanic Whites and American Indians. On renal biopsy, endocapillary proliferative glomerulonephritis was the most common glomerular abnormality, followed by the focal segmental glomerulosclerosis (FSGS)-like pattern. The FSGS-like pattern was more frequent in American Indians and Hispanics than in Non-Hispanic Whites.

Conclusions: This is the first report of an incidence figure of IgAN for an entire state in the US. American Indian and Hispanic patients had a stronger representation in our cohort than Non-Hispanic Whites, when compared to the general New Mexico population.

Citing Articles

External validation of the international prediction tool in Korean patients with immunoglobulin A nephropathy.

Joo Y, Kim H, Baek C, Park J, Lee H, Lim B Kidney Res Clin Pract. 2022; 41(5):556-566.

PMID: 35545218 PMC: 9576458. DOI: 10.23876/j.krcp.22.006.


IgA Nephropathy: An Interesting Autoimmune Kidney Disease.

Rajasekaran A, Julian B, Rizk D Am J Med Sci. 2020; 361(2):176-194.

PMID: 33309134 PMC: 8577278. DOI: 10.1016/j.amjms.2020.10.003.


Distribution of nephrologists and regional variation in the clinical severity of IgA nephropathy at biopsy diagnosis in Japan: a cross-sectional study.

Okabayashi Y, Tsuboi N, Amano H, Miyazaki Y, Kawamura T, Ogura M BMJ Open. 2018; 8(10):e024317.

PMID: 30385449 PMC: 6224759. DOI: 10.1136/bmjopen-2018-024317.


Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994-2011.

Maixnerova D, Jancova E, Skibova J, Rysava R, Rychlik I, Viklicky O J Nephrol. 2014; 28(1):39-49.

PMID: 24756969 DOI: 10.1007/s40620-014-0090-z.


Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis.

Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, Eitner F PLoS Genet. 2012; 8(6):e1002765.

PMID: 22737082 PMC: 3380840. DOI: 10.1371/journal.pgen.1002765.